News Feed Opinion Career Insight Dialogues Blog Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
November, 2024
November 2024
M T W T F S S
 123
45678910
11121314151617
18192021222324
252627282930  
Paolo Tarantino: Great JSMO24 session on HR+ MBC
Photo taken from Paolo Tarantino/X
Feb 27, 2024, 15:23

Paolo Tarantino: Great JSMO24 session on HR+ MBC

Paolo Tarantino, Clinical Research Fellow at Dana-Farber Cancer Institute, recently posted on X/Twitter:

“Great JSMO24 session on HR+ MBC, with Matt Goetz covering new endocrine treatments, myself tasked with reviewing the evolving landscape of targeted drugs, Otto Metzger covering new biomarkers, Hope Rugo exploring recent data with ADCs and chairing by Erika Hamilton and Toru Mukohara.”

Source: Paolo Tarantino/X

cancer Erika Hamilton Hope Rugo JSMO24 Matt Goetz OncoDaily Oncology Otto Metzger Paolo Tarantino Toru Mukohara
Special Coverage
Insight
Nov 3, 2024, 17:46
Rana McKay: Evaluating ACP1 expression in prostrate cancer
Insight
Nov 3, 2024, 17:23
Talha Badar: A predictive model for therapy failure in patients with CML receiving TKI therapy
Insight
Nov 3, 2024, 17:05
Vincent Rajkumar: Survival improvement in patients with HIV associated B cell lymphoma that adopted the Medicaid expansion of ACA
Blog
Nov 3, 2024, 16:51
Addressing cancer disparities among Black women - American Cancer Society
Blog
Nov 3, 2024, 16:48
Mohit Manrao: Discussing cancer innovation and biomarkers at the STAT Summit
Blog
Nov 3, 2024, 16:46
Lindsey Gasparini: New FDA-approved therapy targets Claudin18.2 in gastric cancers
Blog
Nov 3, 2024, 16:45
Nermean Mostafa: Launching a new oncology training platform in Egypt
Blog
Nov 3, 2024, 16:35
Jasmine Kamboj: Honored to be on the ballot for the Designated Community Oncology seat
Blog
Nov 3, 2024, 16:34
Crystal Denlinger: Our biannual guidelines harmonization update meeting
Blog
Nov 3, 2024, 16:30
Yale University's $150M investment into AI leadership is equipping medstudents with the tools to tackle tomorrow's healthcare challenges
Insight
Nov 3, 2024, 16:27
Alessandro Di Federico: EFS in patients with resectable NSCLC treated with neoadjuvant Chemo-IO
Blog
Nov 3, 2024, 16:25
Raising awareness on biomarker information gaps for metastatic breast cancer patients - ABC Global Alliance